“XP-23829, a Novel Fumaric Acid Ester, is Efficacious in Reducing Psoriatic Lesions: Results from a Phase 2 Randomized Controlled Study” (2017) SKIN The Journal of Cutaneous Medicine, 1(3.1), p. s33. doi:10.25251/skin.1.supp.32.